Market revenue in 2021 | USD 21.1 million |
Market revenue in 2028 | USD 26.4 million |
Growth rate | 3.3% (CAGR from 2021 to 2028) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | CareSens Expert Plus |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 51.66% in 2021. Horizon Databook has segmented the Brazil network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
Brazil, being the fifth largest country in the world and most developed in Latin America, is a potential market for POC diagnostic products. Healthcare reforms such as Unified Health System (SUS) in Brazil are estimated to boost the usage rates of POC devices.
Moreover, various initiatives being undertaken by companies in the country to develop efficient POC diagnostic tests are expected to drive the market growth in the coming years. According to International Diabetes Federation, there were around 16.7 million people suffering from diabetes, with prevalence rate of 11.4%, in 2019. Brazil has the most structured healthcare system.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account